AI Engines For more Details: Perplexity Kagi Labs You
Tuberculosis (TB): D-Cycloserine is used as a second-line treatment for tuberculosis, especially when first-line drugs such as isoniazid and rifampicin are ineffective or when the TB bacteria are resistant to them. It works by inhibiting the synthesis of mycobacterial cell walls, thereby killing the bacteria or preventing their growth.
Multi-Drug Resistant Tuberculosis (MDR-TB): D-Cycloserine is particularly useful in the treatment of multi-drug resistant tuberculosis (MDR-TB), a form of TB that is resistant to at least isoniazid and rifampicin, the two most potent anti-TB drugs. D-Cycloserine is often used in combination with other second-line drugs to effectively treat MDR-TB infections.
Extensively Drug Resistant Tuberculosis (XDR-TB): D-Cycloserine may also be used in the treatment of extensively drug-resistant tuberculosis (XDR-TB), which is resistant to multiple first-line and second-line anti-TB drugs. In combination with other antibiotics, d-cycloserine can help combat XDR-TB infections.
Adverse Effects: Common side effects of d-cycloserine include dizziness, drowsiness, headache, nausea, vomiting, and diarrhea. It can also cause neurological side effects such as confusion, depression, anxiety, and hallucinations, particularly at higher doses. Long-term use of d-cycloserine may lead to peripheral neuropathy.
Monitoring: Patients taking d-cycloserine should be closely monitored for adverse effects, especially neurological side effects. Regular assessment of kidney function and liver function may also be necessary. Dosage adjustments or discontinuation of the medication may be required if severe adverse effects occur.
Drug Interactions: D-Cycloserine may interact with other medications, including certain antidepressants, antipsychotics, and anticonvulsants, potentially leading to increased side effects or reduced efficacy of either drug. Healthcare providers should be aware of potential drug interactions and adjust medication doses as needed.
Treatment Duration: The duration of treatment with d-cycloserine for tuberculosis varies depending on the severity of the infection, the presence of drug resistance, and other factors. Treatment regimens are typically prolonged, often lasting for several months to years, and may involve combination therapy with multiple antibiotics.
Rank | Probiotic | Impact |
---|---|---|
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
species | Streptococcus thermophilus | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Pseudobutyrivibrio | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Ligilactobacillus | genus | Decreases |
0 | 1 | Butyrivibrio | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Eubacterium | genus | Decreases |
0 | 1 | Catenibacterium | genus | Decreases |
0 | 1 | Intestinibaculum | genus | Decreases |
0 | 1 | Simiaoa | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Lachnoanaerobaculum | genus | Decreases |
0 | 1 | Subdoligranulum | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Lachnospira eligens | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Enterocloster bolteae | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Romboutsia sp. 13368 | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Rothia dentocariosa | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Clostridioides difficile | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Streptococcus canis | species | Decreases |
0 | 1 | Pusillibacter faecalis | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Campylobacter coli | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.7 | 0.7 | |
ADHD | 1.2 | 0.9 | 0.33 |
Age-Related Macular Degeneration and Glaucoma | 0.6 | 0.6 | |
Allergic Rhinitis (Hay Fever) | 1.8 | 1 | 0.8 |
Allergies | 3.1 | 1.4 | 1.21 |
Allergy to milk products | 1.3 | 0.8 | 0.63 |
Alopecia (Hair Loss) | 0.1 | 0.2 | -1 |
Alzheimer's disease | 3.6 | 4.2 | -0.17 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.7 | 0.8 | 1.13 |
Ankylosing spondylitis | 1.8 | 1.6 | 0.13 |
Anorexia Nervosa | 0.4 | 1.9 | -3.75 |
Antiphospholipid syndrome (APS) | 1.6 | 0.2 | 7 |
Asthma | 3.1 | 1 | 2.1 |
Atherosclerosis | 2.2 | 1.2 | 0.83 |
Atrial fibrillation | 1.7 | 1.3 | 0.31 |
Autism | 5.6 | 5.1 | 0.1 |
Autoimmune Disease | 0.6 | 0.5 | 0.2 |
Barrett esophagus cancer | 0.4 | 0.2 | 1 |
benign prostatic hyperplasia | 0.4 | 0.2 | 1 |
Biofilm | 2 | 2 | |
Bipolar Disorder | 1.1 | 0.8 | 0.38 |
Brain Trauma | 0.3 | 0.9 | -2 |
Breast Cancer | 1.1 | 1.1 | |
Cancer (General) | 0.4 | 0.6 | -0.5 |
Carcinoma | 2.3 | 0.8 | 1.87 |
Celiac Disease | 2.8 | 0.7 | 3 |
Cerebral Palsy | 0.5 | 0.7 | -0.4 |
Chronic Fatigue Syndrome | 2.8 | 4 | -0.43 |
Chronic Kidney Disease | 2 | 1.9 | 0.05 |
Chronic Lyme | 0.1 | 0.6 | -5 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.1 | 1.5 | 0.4 |
Chronic Urticaria (Hives) | 1 | 1.1 | -0.1 |
Coagulation / Micro clot triggering bacteria | 1 | 1.2 | -0.2 |
Cognitive Function | 0.8 | 0.8 | 0 |
Colorectal Cancer | 6.1 | 1.8 | 2.39 |
Constipation | 1.4 | 0.4 | 2.5 |
Coronary artery disease | 2.2 | 2.3 | -0.05 |
COVID-19 | 4.2 | 7.6 | -0.81 |
Crohn's Disease | 6.3 | 3.1 | 1.03 |
Cushing's Syndrome (hypercortisolism) | 0.8 | -0.8 | |
cystic fibrosis | 0.7 | 0.6 | 0.17 |
d-lactic acidosis (one form of brain fog) | 0.6 | 0.6 | |
deep vein thrombosis | 2.6 | 1.4 | 0.86 |
Denture Wearers Oral Shifts | 1.6 | 1.6 | |
Depression | 5 | 4 | 0.25 |
Dermatomyositis | 0.2 | 0.2 | |
Eczema | 1.8 | 1.6 | 0.13 |
Endometriosis | 1.8 | 1.4 | 0.29 |
Eosinophilic Esophagitis | 0.4 | 0.2 | 1 |
Epilepsy | 2.8 | 0.3 | 8.33 |
erectile dysfunction | 1.1 | 1.1 | |
Fibromyalgia | 0.8 | 1.8 | -1.25 |
Functional constipation / chronic idiopathic constipation | 4 | 2.8 | 0.43 |
gallstone disease (gsd) | 2.4 | 0.9 | 1.67 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 2.3 | 1.1 | 1.09 |
Generalized anxiety disorder | 2.6 | 1 | 1.6 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.1 | 0.2 | -1 |
Gout | 0.5 | 0.6 | -0.2 |
Graves' disease | 0.3 | 1.2 | -3 |
Gulf War Syndrome | 0.6 | 1 | -0.67 |
Halitosis | 1.5 | 0.3 | 4 |
Hashimoto's thyroiditis | 2.2 | 0.9 | 1.44 |
Heart Failure | 3.6 | 1.2 | 2 |
hemorrhagic stroke | 0.5 | 0.5 | |
Hidradenitis Suppurativa | 1 | 1 | |
High Histamine/low DAO | 1.1 | 0.1 | 10 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.2 | 2 |
hyperglycemia | 1.4 | 0.3 | 3.67 |
Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
hypersomnia | 0.2 | -0.2 | |
hypertension (High Blood Pressure | 1.3 | 3.1 | -1.38 |
Hypothyroidism | 0.1 | 0.6 | -5 |
Hypoxia | 0.5 | 0.5 | |
IgA nephropathy (IgAN) | 0.9 | 2.7 | -2 |
Inflammatory Bowel Disease | 6.5 | 5.7 | 0.14 |
Insomnia | 1.7 | 1 | 0.7 |
Intelligence | 1.4 | 0.8 | 0.75 |
Intracranial aneurysms | 0.7 | 0.5 | 0.4 |
Irritable Bowel Syndrome | 4.6 | 2.7 | 0.7 |
ischemic stroke | 1 | 1.1 | -0.1 |
Juvenile idiopathic arthritis | 0.1 | -0.1 | |
Liver Cirrhosis | 4.3 | 2.7 | 0.59 |
Long COVID | 4.7 | 3.6 | 0.31 |
Low bone mineral density | 1.3 | -1.3 | |
Lung Cancer | 0.5 | 0.5 | 0 |
Lymphoma | 0.4 | 0.4 | |
Mast Cell Issues / mastitis | 1.2 | 0.5 | 1.4 |
ME/CFS with IBS | 0.5 | 2.4 | -3.8 |
ME/CFS without IBS | 1.4 | 0.8 | 0.75 |
membranous nephropathy | 0.2 | 0.2 | |
Menopause | 0.5 | 0.5 | 0 |
Metabolic Syndrome | 5.1 | 4.4 | 0.16 |
Mood Disorders | 4.6 | 2.6 | 0.77 |
multiple chemical sensitivity [MCS] | 0.9 | 0.1 | 8 |
Multiple Sclerosis | 3 | 3.5 | -0.17 |
Multiple system atrophy (MSA) | 0.3 | 0.1 | 2 |
myasthenia gravis | 0.6 | 0.5 | 0.2 |
neuropathic pain | 1 | -1 | |
Neuropathy (all types) | 0.2 | 0.7 | -2.5 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.4 | 2.1 | 0.62 |
NonCeliac Gluten Sensitivity | 0.2 | 0.2 | 0 |
Obesity | 5.9 | 5.7 | 0.04 |
obsessive-compulsive disorder | 3.5 | 2.2 | 0.59 |
Osteoarthritis | 2.3 | 1 | 1.3 |
Osteoporosis | 1.2 | 0.5 | 1.4 |
pancreatic cancer | 0.8 | 0.2 | 3 |
Parkinson's Disease | 5.1 | 5.4 | -0.06 |
Polycystic ovary syndrome | 4.5 | 1.2 | 2.75 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.3 | -2 |
primary biliary cholangitis | 0.3 | 0.8 | -1.67 |
Primary sclerosing cholangitis | 1.1 | 2.1 | -0.91 |
Psoriasis | 1.7 | 1.5 | 0.13 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.5 | 2.4 | 0.88 |
Rosacea | 0.3 | 0.6 | -1 |
Schizophrenia | 2.6 | 1.4 | 0.86 |
scoliosis | 1.2 | 0.4 | 2 |
sensorineural hearing loss | 0.5 | 0.5 | |
Sjögren syndrome | 1.3 | 0.6 | 1.17 |
Sleep Apnea | 1.2 | 0.9 | 0.33 |
Slow gastric motility / Gastroparesis | 0.9 | 0.9 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 2 | 2 | |
Stress / posttraumatic stress disorder | 1.7 | 1.1 | 0.55 |
Systemic Lupus Erythematosus | 3.3 | 1 | 2.3 |
Tic Disorder | 0.9 | 1.1 | -0.22 |
Tourette syndrome | 0.2 | 0.2 | 0 |
Type 1 Diabetes | 2.9 | 2.2 | 0.32 |
Type 2 Diabetes | 6.2 | 4.5 | 0.38 |
Ulcerative colitis | 4.2 | 4.8 | -0.14 |
Unhealthy Ageing | 4.2 | 0.9 | 3.67 |
Vitiligo | 1.4 | 0.8 | 0.75 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]